Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as an injection solution for intra‑arterial and intravenous use. It provides radiodensity that enhances the visibility of vascular structures and soft tissues during imaging procedures such as angiography and computed tomography scans.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iomeron, an iodinated contrast agent, is used to enhance radiographic visualization in vascular and cross‑sectional imaging.

- Angiography: improves vessel delineation for diagnostic and interventional procedures - Computed Tomography (CT) imaging: increases contrast between tissues for clearer diagnostic images - CT angiography: combines CT imaging with contrast to visualize blood vessels

Iomeron may cause a range of adverse reactions, from mild to severe. Patients should be monitored during and after administration.

Common Side Effects: - Warm sensation at the injection site - Altered taste sensation - Nausea - Vomiting

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Contrast‑induced nephropathy - Thyroid dysfunction (hyper‑ or hypothyroidism)

Prior to using Iomeron, clinicians should evaluate patient risk factors and follow handling guidelines.

- Renal impairment: assess kidney function before administration - History of iodine allergy: evaluate risk and consider pre‑medication - Thyroid disease: monitor thyroid function tests - Pregnancy: use only when essential for maternal care - Drug interactions: avoid concurrent use with other iodinated contrast agents - Store below 25°C: keep in original container, protect from light and moisture

Iomeron can interact with certain medications and agents; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - Concurrent administration with other iodinated contrast agents: risk of cumulative iodine load - High‑dose metformin in patients with renal dysfunction: risk of lactic acidosis

Moderate Interactions (Monitor Closely): - Nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): monitor renal function - Thyroid hormone therapy: watch for changes in thyroid status - Beta‑blockers: may mask symptoms of contrast reaction